AzTrials
AzTrials

ExerciseIPENCT04016350

Impact of Exercise Combined With Inulin Propionate Ester on Fat Oxidation

A study testing Exercise training with Inulin Propionate Ester in people with Exercise and Inulin Propionate Ester, run by University of Glasgow.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is evidence to suggest that responsiveness to exercise training programmes can be expected to be influenced by changes in resting fat oxidation, an important factor in the aetiology of obesity. Read more about this study

Who is it for?
Ages 25 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Exercise, Inulin Propionate Ester
What is being tested?
Exercise training with Inulin Propionate Ester
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
No sites listed yet
Study dates
5 Feb 2015to 11 Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy, sedentary and overweight females with BMI >25 kg/m2 and stable body weight for two months prior to the study.

Who cannot join

  • Acute or chronic illness, eating disorders, history of gastrointestinal operations, smoking, pregnancy, taking supplements, and being on specific diet for the past three months.

About this study

Official title: Impact of Moderate Intensity Exercise Training Combined With Inulin Propionate Ester Supplementation on Whole Body Resting Fat Oxidation and Body Weigh in Overweight Women

There is evidence to suggest that responsiveness to exercise training programmes can be expected to be influenced by changes in resting fat oxidation, an important factor in the aetiology of obesity. Our previous work has shown that oral supplementation with inulin propionate ester (IPE) reduces intra-abdominal fat and prevents weight gain and that oral propionate intake enhances resting fat oxidation. The effects of IPE combined with exercise training on resting fat oxidation and body fatness are unknown. The aim of this study was to investigate the impact of 4-weeks IPE supplementation, in combination with a moderate intensity exercise training programme, on whole body fat oxidation and on plasma GLP-1 and PYY.

Read the detailed description

Participants: Healthy overweight females with BMI >25 kg/m2 and 25-45 years of age were recruited through advertisements and word of mouth on the campus of the University of Glasgow or from other public places. Participants were required to be sedentary, non-smokers, with stable body weight for two months prior to the study enrollment, not pregnant, free of medication, nutritional supplementation or following any specific diet and with no antibiotic use for the past three months. Participants with chronic illness, eating disorders and history of gastrointestinal operations were excluded.

Study Design: This is a randomized study with a parallel design. Study participants underwent 4 week supervised moderate intensity exercise training combined either with IPE (EX/IPE) or cellulose as placebo (EX/Placebo) supplementation at doses of 10g / day. Supplements were provided as sachets containing white powder and participants were asked to consume one sachet per day with breakfast in a way convenient for each participant. Before the start of the study and at the end of the 4-week intervention, participants were asked to conduct a submaximal exercise test. Prior to the first and after the second submaximal exercise test, participants of both groups conducted a 7-hour experimental trial which involved collection of expired air and blood samples in fasted and postprandial states. Body weight and body composition were measured in the fasted state. Prior to the first 7-hour experimental trial, participants were asked to record their diet for 3 days and replicate this intake prior to the second 7-hour experimental trial.

Being tested
Exercise training with Inulin Propionate Ester, Exercise training with placebo
Keywords
Exercise,, Inulin Propionate Ester, Gut hormones, Body weigh, Fat oxidation, Overweight women
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise training with Inulin Propionate EsterBehavioural

    Supervised moderate intensity exercise training combined with Inulin Propionate Ester supplementation conducted for 4 weeks.

  • Exercise training with placeboBehavioural

    Supervised moderate intensity exercise training combined with placebo conducted for 4 weeks

Study groups in NCT04016350
Study groupRoleWhat they receive
Exercise Training with Inulin Propionate EsterExperimentalStudy participants underwent 4 week supervised moderate intensity exercise training combined with Inulin Propionate Ester supplementation at doses of 10g / day.
Receives: Behavioral: Exercise training with Inulin Propionate Ester
Exercise Training with PlaceboExperimentalStudy participants underwent 4 week supervised moderate intensity exercise training combined with cellulose as placebo at doses of 10g / day.
Receives: Behavioral: Exercise training with placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Resting fat oxidation

    Changes in resting fat oxidation measured in the fasted and postprandial states by means of indirect calorimetry (Oxycon Pro, Germany).

    Measured: 4 weeks

  2. Resting carbohydrate oxidation

    Changes in resting fat oxidation measured in the fasted and postprandial states by means of indirect calorimetry (Oxycon Pro, Germany).

    Measured: 4 weeks

  3. Metabolic rate

    Changes in resting energy expenditure measured in the fasted and postprandial states by means of indirect calorimetry (Oxycon Pro, Germany).

    Measured: 4 weeks

Secondary outcomes (6)
  1. Body weight

    Changes in body weight measured by TANITA scales (TBF-300).

    Measured: 4 weeks

  2. Body fat (%)

    Changes in body fat expressed as percentage (proportion of fat to the total body weight) measured by TANITA scales (TBF-300).

    Measured: 4 weeks

  3. Maximal oxygen consumption [Time Frame: 4 weeks]

    Changes in maximal oxygen consumption (ml/kg/min) measured by Servomex Gas Analyser.

    Measured: 4 weeks

  4. Peptide YY (PYY)

    Changes in plasma concentration of fasting and postprandial PYY measured using ELISA (Merc Millipore) kit.

    Measured: 4 weeks

  5. Glucagon-like peptide-1 (GLP-1)

    Changes in plasma concentration of fasting and postprandial GLP-1 measured using ELISA (Merc Millipore) kit.

    Measured: 4 weeks

  6. Height

    Height (meters)measured by stadiometer, a vertical ruler with a sliding horizontal paddle which is adjusted to rest on the top of the head.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2019
  2. Study start5 Feb 2015
  3. Primary completion10 Mar 2017
  4. Study completion11 Jun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a randomised study with parallel design. Study participants underwent 4 week supervised moderate intensity exercise training combined either with IPE or cellulose as placebo supplementation at doses of 10g/day. Measurements were done before and after intervention
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04016350
Sponsor's protocol ID
UGlasgow IPE
Other IDs
BB/L004259/1
Acronym
IPE
Status last verified
Jul 2019
First submitted
5 Jul 2019
Last updated
11 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Malkova D, Polyviou T, Rizou E, Gerasimidis K, Chambers ES, Preston T, Tedford MC, Frost G, Morrison DJ. Moderate intensity exercise training combined with inulin-propionate ester supplementation increases whole body resting fat oxidation in overweight women. Metabolism. 2020 Mar;104:154043. doi: 10.1016/j.metabol.2019.154043. Epub 2019 Nov 29.

    PubMed 31790692

Questions about this trial

What is this clinical trial studying?

A study testing Exercise training with Inulin Propionate Ester in people with Exercise and Inulin Propionate Ester, run by University of Glasgow.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Resting fat oxidation (time frame: 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04016350, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in